Smith Group Asset Management’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
Other funds holding KYNB
Smith Group Asset Management's KYNB Position: Q1 2022 in Review
Smith Group Asset Management sold out of Kyntra Bio (KYNB) in Q1 2022, closing a stake of 3 shares — an estimated $1K sold.
Smith Group Asset Management first reported a position in KYNB in Q3 2015 and held it in 26 quarters. The position peaked at $1.1M in Q4 2015. 156 funds tracked by Wall St. Rank hold KYNB as of Q1 2022.
- Smith Group Asset Management reported no remaining Kyntra Bio position as of Q1 2022 after selling out during the quarter.
- Smith Group Asset Management sold 3 Kyntra Bio shares in Q1 2022, an estimated $1K.
- Smith Group Asset Management first reported a position in Kyntra Bio in Q3 2015 and held it in 26 quarters.
- Smith Group Asset Management's Kyntra Bio position peaked at $1.1M in Q4 2015.
- 156 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2022.
Based on Smith Group Asset Management's 13F filing for Q1 2022, filed 5 May 2022.